Health (Corporate Policies – COVID)

​

• Drafting and implementation of more than one hundred (100) corporate forms and policies, related specifically to all aspects of corporate operations that may be impacted by COVID, including but not limited to: abatement plans; back-to-school employee accommodation protocols; board resolutions; building modifications; commercial landlord-tenant issues; commercial lease amendments and modifications; compliance with Executive Orders; compliance with applicable Federal, state and local guidelines, local laws, policies, statutes, regulations, rules; compliance with the Occupational Safety and Health Act (OSHA) and Occupational Safety and Health Administration (OSHA) guidelines; communicable disease policy; confirmed-positive protocols; contact-tracing onsite; control plans; corporate resolutions; data privacy protocols; data security protocols; data use protocols; email notices to employees; employee acknowledgement of onsite protective measures implemented by management; employee handbook; federal constitutional issues; Health Insurance Portability and Accountability Act (HIPAA) disclosure protocols; home testing; hotline protocols; hybrid home-onsite work plans; infectious disease policy; leave of absence protocols; maintenance plans; masking protocols; new hire protocols; notices to employees; office layout; onsite screening for employees; onsite screening for visitors; onsite testing; medical exemptions; mitigation plans; payment protocols; preparedness plans; prevention plans; recall to onsite work notices; recruiting protocols; religious exemptions; remote and virtual meetings (chat, phone calls, teleconference, video teleconference and the like) protocols; requests for additional paid time off (PTO); requests for emergency paid sick leave; sanitation plans; state constitutional issues; termination notices for failure to comply with corporate policies; termination notices for refusal to return to onsite work; travel protocols; website FAQ and Q&A pages; work-at-home standards (including key performance indicators – KPIs – and performance criteria).

​

• Variations of all policies and protocols by state, particularly regarding medical and religious exemptions.

​

• Continuing legal analysis of current issues (for example: the recent United States Supreme Court contradictory rulings, upholding the Maine ban on religious exemptions while simultaneously allowing religious exemptions in New York; the lawsuits by numerous States challenging the various mandates; and, the recent 5th Circuit Appellate Court order blocking the further implementation of the mandates).

​

• Analysis of the Food and Drug Administration’s (FDA) Emergency Use Authorizations (EUAs).

​

• Analysis of requests for medical and religious exemptions.

​

    Progress_Page_Last_Updated_211112_1421